ReviewJournal of translational medicine2016

Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments.

Rong Biaoxue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.